Investor Relations. KKR & Co. Inc. 30 Hudson Yards New York, New York 10001 United States. Craig Larson Telephone: +1 (877) 610-4910 Outside US: +1 (212) 230-9410 Facsimile: +1 (212) 750-0003 Email: [email protected]

This presentation may contain certain forward-looking statements pertaining to KKR, including with respect to the investment funds, and vehicles and accounts managed by KKR and the Global Atlantic insurance companies.

Before viewing this presentation, please acknowledge your understanding that it has been prepared for KKR & Co. Inc. (NYSE:KKR) for the benefit of its public stockholders and is not intended to be a solicitation or sale of any of the securities, funds or services that it may discuss.

Before viewing this presentation, please acknowledge your understanding that it has been prepared for KKR & Co. Inc. (NYSE:KKR) for the benefit of its public stockholders and is not …

KKR & Co. Inc. to Announce Fourth Quarter 2024 Results January 9, 2025 KKR and PSP Investments Acquire Minority Stake in Two American Electric Power Transmission Companies

February 4, 2025 Upcoming KKR & Co. Inc. Fourth Quarter 2024 Financial Results Conference Call at 10:00am ET

Jan 25, 2025 · KKR & Co. Inc. Announces Date Change for its Conference Call to Discuss Fourth Quarter 2024 Results

Before viewing this presentation, please acknowledge your understanding that it has been prepared for KKR & Co. Inc. (NYSE:KKR) for the benefit of its public stockholders and is not intended to be a solicitation or sale of any of the securities, funds or services that it may discuss.

WOBURN, MA – Azurity Pharmaceuticals, Inc. (“Azurity”) is pleased to announce the closing of its acquisition of Slayback Pharma LLC (“Slayback”) today from existing investors including KKR, a leading global investment firm, and Everstone Capital. Slayback is now a …

)250 >@&khfnwklver[liqrorqjhu vxemhfwwr6hfwlrq )rup ru)rup reoljdwlrqvpd\ frqwlqxh 6hh ,qvwuxfwlrq e 81,7('67 $ 7(66(&85,7,(6 $1'(;&+$1*(&200,66,21